Human Immunodeficiency Virus (HIV) Type 1 Reverse Transcriptase Resistance Mutations in Hepatitis B Virus (HBV)-HIV-Coinfected Patients Treated for HBV Chronic Infection Once Daily with 10 Milligrams of Adefovir Dipivoxil Combined with Lamivudine

Adefovir dipivoxil (ADV) at a suboptimal concentration for human immunodeficiency virus type 1 (HIV-1) (10 mg once daily) can be used to treat hepatitis B virus (HBV) infection in HIV-1-HBV-coinfected patients and does not, even in the case of uncontrolled HIV-1 replication, select for either ADV mu...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Delaugerre, Constance, Marcelin, Anne-Geneviève, Thibault, Vincent, Peytavin, Gilles, Bombled, Tony, Bochet, Marie-Valérie, Katlama, Christine, Benhamou, Yves, Calvez, Vincent
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 2002
Teme:	Antiviral Agents
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127167/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11959607/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.5.1586-1588.2002
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!